Abstract
In the present study, the various 28 hybrid molecules containing hydrazone and sulfonate moieties were synthesized and characterized by FTIR, 1H-NMR, 13C-NMR spectroscopy and LC-MS spectrometry, besides elemental analysis. The compounds were evaluated for their antiproliferative effects against six cancer cell lines, namely A549 (non-small cell lung cancer), MCF-7 (breast cancer), HT-29 (colorectal adenocarcinoma cancer), PC-3 (androgen-independent prostate adenocarcinoma), Hep3B (hepatocellular carcinoma cancer), and HeLa (epitheloid cervix carcinoma cancer). Among all the target compounds, compounds 4g and 4h exhibited more promising effects on MCF-7 cell lines (IC50 = 17.8 μM and 21.2 μM, respectively) with high selectivity. Further mechanistic studies proposed that compounds 4g and 4h induced apoptosis is mediated through the intrinsic apoptotic pathway with changes in mitochondrial membrane potential by finally activating caspase-9 and caspase-3. The results have been encouraging enough to merit further investigation.
Similar content being viewed by others
References
Rollas S, Küçükgüzel ŞG. Biological activities of hydrazone derivatives. Molecules. 2007;12:1910–39. https://doi.org/10.1016/j.ejmech.2003.08.004.
Şenkardeş S, Kaushik-Basu N, Durmaz I, Manvar D, Basu A, Atalay R, et al. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors. Eur J Med Chem. 2016;108:301–8. https://doi.org/10.1016/j.ejmech.2015.10.041.
Zhang D, Ma Y, Liu Y, Liu ZP. Synthesis of sulfonylhydrazone- and acylhydrazone-substituted 8-ethoxy-3-nitro-2H-chromenes as potent antiproliferative and apoptosis inducing agents. Arch Pharm. 2014;347:576–88. https://doi.org/10.1002/ardp.201400082.
Küçükgüzel G, Koç D, Çikla-Süzgün P, Özsavci D, Bingöl-Özakpinar Ö, Mega-Tiber P, et al. Synthesis of tolmetin hydrazide-hydrazones and discovery of a potent apoptosis inducer in colon cancer cells. Arch Pharm. 2015;348:730–42. https://doi.org/10.1002/ardp.201500178.
Han Mİ, Atalay P, Tunç CÜ, Ünal G, Dayan S, Aydın Ö, et al. Design and synthesis of novel (S)-naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models. Bioorg Med Chem. 2021;37:116097 https://doi.org/10.1016/j.bmc.2021.116097.
Nechepurenko IV, Shirokova ED, Khvostov MV, Frolova TS, Sinitsyna OI, Maksimov AM, et al. Synthesis, hypolipidemic and antifungal activity of tetrahydroberberrubine sulfonates. Russ Chem Bull. 2019;68:1052–60. https://doi.org/10.1007/s11172-019-2519-y.
Chen S, Zhang Y, Liu Y, Wang Q. Design, synthesis, acaricidal activities, and structure-activity relationship studies of novel oxazolines containing sulfonate moieties. J Agric Food Chem. 2019;67:13544–9. https://doi.org/10.1021/acs.jafc.9b05547.
Bagul SD, Rajput JD, Patil MM, Bendre RS. Synthesis, characterization and antioxidant activity of carvacrol based sulfonates. Med Chem. 2017;7:294–8. https://doi.org/10.4172/2161-0444.1000470.
Grindrod S, Suy S, Fallen S, Eto M, Toretsky J, Brown ML. Effects of a fluorescent myosin light chain phosphatase inhibitor on prostate cancer cells. Front Oncol. 2011;1:1–17. https://doi.org/10.3389/fonc.2011.00027.
Fortin S, Charest-Morin X, Turcotte V, Lauvaux C, Lacroix J, Côté MF, et al. Activation of phenyl 4-(2-Oxo-3-Alkylimidazolidin-1-yl)benzenesulfonates prodrugs by CYP1A1 as new antimitotics targeting breast cancer cells. J Med Chem. 2017;60:4963–82. https://doi.org/10.1021/acs.jmedchem.7b00343.
Krueger AB, Dehdashti SJ, Southall N, Marugan JJ, Ferrer M, Li X, et al. Identification of a selective small-molecule inhibitor series targeting the eyes absent 2 (Eya2) phosphatase activity. J Biomol Screen. 2013;18:85–96. https://doi.org/10.1177/1087057112453936.
Dorababu A. Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles. Heliyon. 2020;6:e03656. https://doi.org/10.1016/j.heliyon.2020.e03656.
Han Mİ, Bekçi H, Cumaoğlu A, Küçükgüzel G. Synthesis and characterization of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen as anticancer agents. Marmara Pharm J. 2018;22:559–69. https://doi.org/10.12991/jrp.2018.98.
Şenkardeş S, Türe A, Ekrek S, Durak AT, Abbak M, Çevik Ö, et al. Novel 2,6-disubstituted pyridine hydrazones: Synthesis, anticancer activity, docking studies and effects on caspase-3-mediated apoptosis. J Mol Struct. 2021;1223:1–9. https://doi.org/10.1016/j.molstruc.2020.128962.
Küçükgüzel SG, Mazi A, Sahin F, Öztürk S, Stables J. Synthesis and biological activities of diflunisal hydrazide-hydrazones. Eur J Med Chem. 2003;38:1005–13. https://doi.org/10.1016/j.ejmech.2003.08.004.
Çikla P, Arora P, Basu A, Talele TT, Kaushik-Basu N, Küçükgüzel ŞG. Etodolac thiosemicarbazides: a novel class of hepatitis C virus NS5B polymerase inhibitors. Marmara Pharm J. 2013;17:138–46. https://doi.org/10.12991/201317382.
Amir M, Kumar S. Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of 3,5-dimethyl pyrazoles, 3-methyl pyrazol-5-ones and 3,5-disubstituted pyrazolines. Indian J Chem Sect B Org Med Chem. 2005;44:2532–7. https://doi.org/10.1002/chin.200615110.
Karakuş S, Rollas S. Synthesis and antimycobacterial activity of some 2-(4-aminophenyl)-5-substituted amino-1,3,4-thiadiazole derivatives and their coupling products. Marmara Pharm J. 2016;20:199–206. https://doi.org/10.12991/mpj.20162013533.
Khasawneh R, Kornreich R. Synthesis,characterization and anti-inflammatory activity of 5- substituted phenyl-N-(6-(propylthio)-1H-benzo[d]imidazol-2-yl) -1, 3, 4-oxadiazol-2-amines. Pharmacogenomics. 1809;3:781–91.
Şenkardeş S, Han Mİ, Kulabaş N, Abbak M, Çevik Ö, Küçükgüzel İ, et al. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Mol Divers. 2020;24:673–89. https://doi.org/10.1007/s11030-019-09974-z.
Mao PCM, Mouscadet JF, Leh H, Auclair C, Hsu LY. Chemical modification of coumarin dimer and HIV-1 integrase inhibitory activity. Chem Pharm Bull. 2002;50:1634–7. https://doi.org/10.1248/cpb.50.1634.
Samrin F, Sharma A, Khan IA, Puri S. Synthesis and antibacterial activity of new diaryldiamines. J Heterocycl Chem. 2012;49:1391–7. https://doi.org/10.1002/jhet.1040.
Aydin S, Kaushik-Basu N, Arora P, Basu A, Nichols DB, Talele TT. et al. Microwave assisted synthesis of some novel flurbiprofen hydrazide hydrazones as anti-HCV NS5B and anticancer agents. Marmara Pharm J. 2013;17:26–34. https://doi.org/10.12991/201317389.
Nowak G. Protein kinase C-α and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na+ transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem. 2002;277:43377–88. https://doi.org/10.1074/jbc.M206373200.
Utsuro M. Neutron spin interference visibility in tunneling transmission through magnetic resonators. Phys B Condens Matter. 2005;358:232–46. https://doi.org/10.1016/j.physb.2005.01.398.
Pistritto G, Trisciuoglio D, Ceci C, Alessia G, D’Orazi G. Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8:603–19. https://doi.org/10.18632/aging.100934.
Kang MH, Reynolds CP. BcI-2 Inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res. 2009;15:1126–32. https://doi.org/10.1158/1078-0432.CCR-08-0144.
Taşkin Tok T, Özaşik Ö, Sarigöl D, Uzgören Baran A. Synthesis and molecular modeling studies of naproxen-based acyl hydrazone derivatives. Turkish J Chem. 2015;39:64–83. https://doi.org/10.3906/kim-1401-91.
Kulabaş N, Özakpinar ÖB, Özsavcı D, Leyssen P, Neyts J, Küçükgüzel İ. Synthesis, characterization and biological evaluation of thioureas, acylthioureas and 4-thiazolidinones as anticancer and antiviral agents. Marmara Pharm J. 2017;21:371–84. https://doi.org/10.12991/marupj.300913.
Bingöl Özakpinar Ö, Türe A, Küçükgüzel İ. Molecular modeling and assessment of cytotoxic and apoptotic potentials of imatinib analogues featuring (Thio)urea motifs in human leukemia and lymphoma cells. J Res Pharm. 2020;24:801–11. https://doi.org/10.35333/jrp.2020.239.
Acknowledgements
This work was supported financially by the Scientific and Technological Research Council of Turkey (TUBITAK) (Project Number: 118S840).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Şenkardeş, S., İhsan Han, M., Gürboğa, M. et al. Synthesis and anticancer activity of novel hydrazone linkage-based aryl sulfonate derivatives as apoptosis inducers. Med Chem Res 31, 368–379 (2022). https://doi.org/10.1007/s00044-021-02837-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-021-02837-z